World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
27012
World Ranking
11424
National Ranking
5858

Overview

Andrew F. Shorr is affiliated with George Washington University in the United States. Their research primarily focuses on medicine with extensive contributions in epidemiology, critical care and intensive care medicine, applied microbiology and biotechnology, pharmacology, and molecular medicine. Their work covers a broad spectrum of topics related to infectious diseases and critical care.

The scientist has published extensively on key subjects including:

  • Pneumonia and Respiratory Infections
  • Nosocomial Infections in ICU
  • Antibiotic Use and Resistance
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Resistance in Bacteria
  • Bacterial Identification and Susceptibility Testing
  • Sepsis Diagnosis and Treatment

Several frequent co-authors have collaborated with Andrew F. Shorr, reflecting ongoing research partnerships. These co-authors include Marya D. Zilberberg, Brian H. Nathanson, Kate Sulham, Marin H. Kollef, and Laura Puzniak.

Andrew F. Shorr's publication record features articles in various scientific journals. The most common venues include Open Forum Infectious Diseases, Antibiotics, CHEST Journal, Critical Care Medicine, and Critical Care. This demonstrates the scientist's focus on critical care and infectious disease disciplines.

Among recent papers authored or co-authored by Andrew F. Shorr are:

  • "Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial", 2020, The Lancet Infectious Diseases
  • "Efficacy and safety of sulbactam-durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii-calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)", 2023, The Lancet Infectious Diseases
  • "Nosocomial Infection", 2021, Critical Care Medicine
  • "Timing of antibiotic therapy in the ICU", 2021, Critical Care
  • "Characteristics, Hospital Course, and Outcomes of Patients Requiring Prolonged Acute Versus Short-Term Mechanical Ventilation in the United States, 2014-2018", 2020, Critical Care Medicine

Best Publications

  • Epidemiology and Outcomes of Health-care–Associated Pneumonia: Results From a Large US Database of Culture-Positive Pneumonia

    Marin H. Kollef;Andrew Shorr;Ying P. Tabak;Vikas Gupta

  • Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis

    Christopher J. Lettieri;Steven D. Nathan;Scott D. Barnett;Shahzad Ahmad

  • Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

    Richard G. Wunderink;Michael S. Niederman;Marin H. Kollef;Andrew F. Shorr

  • Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations.

    Derek C. Angus;Andrew F. Shorr;Alan White;Tony T. Dremsizov

  • Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005.

    Marya D. Zilberberg;Andrew F. Shorr;Marin H. Kollef

  • Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

    Richard G. Wunderink;Yuko Matsunaga;Mari Ariyasu;Philippe Clevenbergh

  • Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant

    A F Shorr;J L Wainright;C S Cors;C J Lettieri

  • Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database.

    Andrew F. Shorr;Ying P. Tabak;Aaron D. Killian;Vikas Gupta

  • Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study

    Marya D Zilberberg;Andrew F Shorr;Scott T Micek;Cristina Vazquez-Guillamet

  • Dynamic evolution of coagulopathy in the first day of severe sepsis : Relationship with mortality and organ failure

    Jean-Francois Dhainaut;Andrew F. Shorr;William L. Macias;Marin J. Kollef

  • Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

    Ethan Rubinstein;Tahaniyat Lalani;G. Ralph Corey;Zeina A. Kanafani

  • Economic implications of an evidence-based sepsis protocol: Can we improve outcomes and lower costs?*

    Andrew F. Shorr;Scott T. Micek;William L. Jackson;Marin H. Kollef

  • Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia.

    Andrew F. Shorr;Marya D. Zilberberg;Scott T. Micek;Marin H. Kollef

  • Red blood cell transfusion and ventilator-associated pneumonia: A potential link?

    Andrew F. Shorr;Mei-Sheng Duh;Kathleen M. Kelly;Marin H. Kollef

  • Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies

    Andrew F. Shorr;Mark J. Kunkel;Marin Kollef

  • Ventilator-Associated Pneumonia: The Clinical Pulmonary Infection Score as a Surrogate for Diagnostics and Outcome

    Marya D. Zilberberg;Andrew F. Shorr

  • A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

    Matteo Bassetti;Monia Marchetti;Arunaloke Chakrabarti;Sergio Colizza

  • Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis

    Andrew F. Shorr;John H. Sherner;William L. Jackson;Marin H. Kollef

  • Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit.

    Andrew F. Shorr

  • Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis.

    Andrew F. Shorr;Kevin Chung;William L. Jackson;Paige E. Waterman

Frequent Co-Authors

Marin H. Kollef
Marin H. Kollef Washington University in St. Louis
Jeffrey Lipman
Jeffrey Lipman University of Queensland
Michael S. Niederman
Michael S. Niederman Cornell University
Daren K. Heyland
Daren K. Heyland Queen's University
Matteo Bassetti
Matteo Bassetti University of Genoa
Vikas Gupta
Vikas Gupta Princess Margaret Cancer Centre
Richard G. Wunderink
Richard G. Wunderink Northwestern University
G. Ralph Corey
G. Ralph Corey Duke University
Jason A. Roberts
Jason A. Roberts University of Queensland
Jean-François Timsit
Jean-François Timsit Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare careers beyond becoming a doctor, several online degree options can offer flexible and affordable pathways. Fields like health information management remain in high demand, and there are accredited HIM programs that allow students to study remotely while preparing for vital data and compliance roles in medical settings.

Many are also considering the average cost of medical billing and coding program options, which make it possible to enter the workforce quickly without a four-year degree. These programs deliver core skills for managing insurance claims and patient records.

For those interested in direct patient care, the cheapest online acute care nurse practitioner programs and other affordable online nursing programs enable students to advance their nursing education at a lower cost. These degrees open doors to specialized roles, higher pay, and greater autonomy.

Whichever path you choose, these online healthcare degrees can help launch or advance your career, often with more flexibility and lower expenses than traditional programs.

Best Scientists Citing Andrew F. Shorr

Trending Scientists